Reported 12 months ago
In the latest episode of Market Domination, hosts Josh Lipton and Seana Smith discuss notable market activities as Fourth of July approaches. Annovis Bio faces stock declines despite promising Parkinson's trial results, while GLP-1 weight-loss drugs trigger stock dips at Novo Nordisk and Eli Lilly. Tesla's stock target has been raised following strong Q2 delivery numbers, indicating a potential turning point for the company. The episode also highlights strategies for investing in software stocks amid ongoing earnings releases.
Source: YAHOO